Summary Stage 2018: Melanoma Skin

Summary Stage 2018

Notes

**Melanoma Skin** 8720-8790 (C000-C002, C006, C210, C440-C449, C500, C510-C512, C518-C519, C600-C602, C608-C609, C632) **Note 1:** The following sources were used in the development of this chapter * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 47 *Melanoma of the Skin*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** For melanoma of sites other than those above * C003-C005, C008-C069, C090-C148, C300-C329: See Melanoma Head and Neck * C690: See Melanoma Conjunctiva * C693, C694: See Melanoma Uvea * For all other sites, use the appropriate site-specific schema **Note 3:** Lymph nodes with isolated tumor cells (ITCs) are counted as positive lymph nodes. ITCs are defined as any tumor deposits in lymph nodes less than or equal to 0.2 mm. **Note 4:** If there is a discrepancy between the Clark level and the pathological description of extent (invasion into the layers of the dermis), use the higher (more extensive) code. **Note 5:** Code the greatest extent of invasion from any procedure performed on the lesion, whether it is described as a biopsy or an excision. For example, if a punch biopsy with involvement of Clark level IV is followed by a re-excision with residual tumor involving Clark level II, code 2 (Clark level IV). **Note 6:** Satellite lesions/nodules or in-transit metastases are coded as regional nodes (code 3).

NAACCR Item

NAACCR #764
SS2018 Description
0 In situ, intraepithelial, noninvasive - Basement membrane of the epidermis is intact - In situ, intraepidermal, intraepithelial, noninvasive + Clark level I
1 Localized only (localized, NOS) - Papillary dermis invaded + Clark level II - Papillary-reticular dermal interface invaded + Clark level III - Reticular dermis invaded + Clark level IV - Skin/dermis, NOS
2 Regional by direct extension only - Subcutaneous tissue (through entire dermis) + Clark level V
3 Regional lymph node(s) involved only - All sites + Regional lymph node(s), NOS * Lymph node(s), NOS - Skin of head and neck (C000-C002, C006, C440-C444) + Levels I-VII + Axillary (neck only, C444) + Cervical, NOS + Deep cervical, NOS + Facial (buccinator, buccal, nasolabial) + Internal jugular, NOS + Parapharyngeal + Parotid (infraauricular, intraparotid, periparotid, preauricular) + Retroauricular (mastoid) + Retropharyngeal + Suboccipital - Skin of upper limb and shoulder (C446) + Axillary + Cervical + Epitrochlear for hand/forearm + Internal mammary (parasternal) + Spinal accessory for shoulder + Supraclavicular (transverse cervical) - Skin of lower limb and hip (C447) + Femoral (superficial inguinal) + Popliteal for heel and calf - Vulva (C510-C512, C518-C519) + Deep inguinal, NOS + Femoral + Inguinal, NOS + Inguinofemoral (groin) + Node of Cloquet or Rosenmuller (highest deep inguinal) + Superficial inguinal (femoral) - Penis (C600-C602, C608-C609) + Iliac, NOS * External * Internal (hypogastric, obturator) + Inguinal, NOS * Node of Cloquet or Rosenmuller (highest deep inguinal) * Superficial [femoral] + Pelvic, NOS - Scrotum (C632) + Iliac, NOS * External * Internal (hypogastric), NOS - Obturator + Inguinal, NOS * Deep inguinal, NOS - Node of Cloquet or Rosenmuller (highest deep inguinal) * Superficial inguinal (femoral)
4 Regional by BOTH direct extension AND regional lymph node(s) involved - Codes (2) + (3)
7 Distant site(s)/lymph node(s) involved - Distant site(s) (including further contiguous extension) + Bone + Central nervous system (CNS) + Lung + Skeletal muscle (including direct extension) + Skin or subcutaneous tissue beyond regional lymph nodes + Underlying cartilage + Visceral metastasis, NOS - Distant lymph node(s), NOS + Axillary (lower trunk) + Femoral (cephalad/caudal) (upper trunk) + Iliac (leg/hip) - Distant metastasis, NOS + Carcinomatosis + Distant metastasis WITH or WITHOUT distant lymph node(s)
9 Unknown if extension or metastasis
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30 (5) Gershenwald, J.E., Scolyer, R.A., et al. **Melanoma of the Skin**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 563-585